Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-007617
Filing Date
2019-02-05
Accepted
2019-02-05 21:23:10
Documents
2
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1626
2 POA DOCUMENT poa.txt EX-24.3_830588 4019
  Complete submission text file 0001209191-19-007617.txt   7118
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 19569701

Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations